Kaplan-Meier survival curves also showed a trend toward poorer prognosis for patients with high FANCD2 expression compared to those with low expression, in terms of both the risk of recurrence ( Figure 1(b , d )) and death ( Figure 2(d )).
← all excerpts
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
1
—
—